Monitoring clinical trials--interim data should be publicly available.
作者信息
Lilford R J, Braunholtz D, Edwards S, Stevens A
机构信息
Department of Public Health and Epidemiology, University of Birmingham, Birmingham B15 2TT.
出版信息
BMJ. 2001 Aug 25;323(7310):441-2. doi: 10.1136/bmj.323.7310.441.
Abstract
摘要
相似文献
1
Monitoring clinical trials--interim data should be publicly available.监测临床试验——期中数据应公开可用。
BMJ. 2001 Aug 25;323(7310):441-2. doi: 10.1136/bmj.323.7310.441.
2
Basics of research (Part 5): Ethics and human rights.
Air Med J. 1996 Jan-Mar;15(1):34-9. doi: 10.1016/s1067-991x(96)90018-8.
3
Stopping rules, interim analyses and data monitoring committees.停止规则、中期分析与数据监测委员会。
Br J Cancer. 1993 Dec;68(6):1047-50. doi: 10.1038/bjc.1993.481.
4
Ethics behind closed doors: do research ethics committees need secrecy?闭门背后的伦理：研究伦理委员会需要保密吗？
BMJ. 2001 May 26;322(7297):1294-6. doi: 10.1136/bmj.322.7297.1294.
5
Health science research ethics: a critique.健康科学研究伦理：一项批判。
Health Law Can. 1993;13(3):192-6.
6
Tips on navigating your research proposal through the institutional review board.
J Emerg Nurs. 2000 Apr;26(2):178-81. doi: 10.1016/s0099-1767(00)90067-9.
7
The institutional review board: an evolving ethics committee.机构审查委员会：一个不断发展的伦理委员会。
J Clin Ethics. 1992 Winter;3(4):278-82.
8
What's new with institutional review boards?机构审查委员会有哪些新情况？
Appl Nurs Res. 2001 Aug;14(3):171-2. doi: 10.1053/apnr.2001.24415.
9
Research policy for nursing services: Part 2.护理服务研究政策：第2部分。
J Nurs Adm. 1981 May;11(5):33-6.
10
In loco parentis. Minimal risk as an ethical threshold for research upon children.代替父母。最低风险作为儿童研究的伦理门槛。
Hastings Cent Rep. 1993 Mar-Apr;23(2):13-9.
引用本文的文献
1
Sharing interim trial results by the Data Safety Monitoring Board with those responsible for the trial's conduct and progress: a narrative review.数据安全监测委员会向负责试验实施和进展的人员分享试验中期结果：一项叙述性综述。
Trials. 2017 Mar 9;18(1):120. doi: 10.1186/s13063-017-1858-y.
2
Value of information: interim analysis of a randomized, controlled trial of goal-directed hemodynamic treatment for aged patients.价值信息：一项针对老年患者目标导向性血流动力学治疗的随机对照试验的中期分析。
Trials. 2013 Jul 9;14:205. doi: 10.1186/1745-6215-14-205.
3
Data sharing among data monitoring committees and responsibilities to patients and science.数据监测委员会之间的数据共享以及对患者和科学的责任。
Trials. 2013 Apr 19;14:102. doi: 10.1186/1745-6215-14-102.
4
Should sponsors and DSMBs share interim results across trials?申办者和数据监查委员会是否应该在各试验间共享期中结果？
J Acquir Immune Defic Syndr. 2011 Dec 15;58(5):433-5. doi: 10.1097/QAI.0b013e318236eca3.
5
Maintaining confidentiality of interim data to enhance trial integrity and credibility.对中期数据保密以提高试验的完整性和可信度。
Clin Trials. 2008;5(2):157-67. doi: 10.1177/1740774508089459.
6
A primer on data safety monitoring boards: mission, methods, and controversies.数据安全监测委员会入门：使命、方法及争议
Intensive Care Med. 2007 Oct;33(10):1815-8. doi: 10.1007/s00134-007-0794-9. Epub 2007 Jul 28.
7
Monitoring clinical trials. Dissemination of decisions on interim analyses needs wider debate.监测临床试验。关于期中分析决策的传播需要更广泛的讨论。
BMJ. 2001 Dec 15;323(7326):1424.
本文引用的文献
1
Preterm breech babies and randomised trials of rare conditions.
Br J Obstet Gynaecol. 1996 Jul;103(7):611-3. doi: 10.1111/j.1471-0528.1996.tb09826.x.
2
Equipoise and the ethics of randomization.equipoise与随机化的伦理问题。
J R Soc Med. 1995 Oct;88(10):552-9.
3
Data monitoring committees and capturing relevant information of high quality.数据监测委员会并收集高质量的相关信息。
Stat Med. 1993 Mar;12(5-6):565-70; discussion 571-3. doi: 10.1002/sim.4780120524.
4
An introduction to the use of interim data analyses in clinical trials.
Ann Emerg Med. 1993 Sep;22(9):1463-9. doi: 10.1016/s0196-0644(05)81997-3.
5
Stopping guidelines for clinical trials with multiple treatments.针对多种治疗方法的临床试验的终止指南。
Stat Med. 1993 May 30;12(10):901-15. doi: 10.1002/sim.4780121002.
6
Stopping rules, interim analyses and data monitoring committees.停止规则、中期分析与数据监测委员会。
Br J Cancer. 1993 Dec;68(6):1047-50. doi: 10.1038/bjc.1993.481.
7
Statistical and ethical issues in monitoring clinical trials.监测临床试验中的统计学和伦理学问题。
Stat Med. 1993 Aug;12(15-16):1459-69; discussion 1471-5. doi: 10.1002/sim.4780121512.
8
Quality control in data monitoring of clinical trials.
Acta Urol Belg. 1994 Apr;62(1):31-5.
9
Early stopping rules--clinical perspectives and ethical considerations.
Stat Med. 1994;13(13-14):1459-69; discussion 1471-2. doi: 10.1002/sim.4780131322.
10
Data Monitoring Committees and early stopping guidelines: the Southwest Oncology Group experience.数据监测委员会与早期终止指南：西南肿瘤协作组的经验
Stat Med. 1994;13(13-14):1391-9. doi: 10.1002/sim.4780131314.
Zotero 插件